Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03091075 · ClinicalTrials.gov registry record · NA
Oxandrolone Rotator Cuff Trial
A NA study of Rotator Cuff Tear, sponsored by University of Southern California.
- Active
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT03091075: Active NA study of Rotator Cuff Tear, sponsored by University of Southern California.
NCT03091075 is a NA study of Rotator Cuff Tear that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 116 participants, above the 83-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03091075, a NA study of Rotator Cuff Tear, is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone (the principal male sex hormone and an anabolic steroid), given for 12 weeks following rotator cuff repair, is effective in aiding in the healing process and restoring muscle mass.
Primary Outcome
assessed by MRI, classified based on the Sugaya classification and Goutallier Grade
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxandrolone
Study Locations (1)
California
- Keck School of Medicine of the University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2018-09-23 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT03091075 still lists
NCT03091075 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% higher).
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03091075 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03091075 about?
NCT03091075 is a clinical study titled "Oxandrolone Rotator Cuff Trial". This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone (the principal male sex hormone and an anabolic steroid), given for 12 weeks following rotator cuff repair, is effe...
What is the current status of trial NCT03091075?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2018-09-23. Estimated completion is 2025-12.
What conditions does trial NCT03091075 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT03091075?
The interventions under investigation include: Placebo (DRUG), Oxandrolone (DRUG).
Who is sponsoring clinical trial NCT03091075?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03091075 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03091075's enrollment target sits among peer trials
116 3rd of 11 higher than 9 of 11 other Rotator Cuff Tear trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
COMPLETED · NA
-
Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot
COMPLETED · NA
-
BioWick SureLock Clinical Outcomes Study
COMPLETED · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI